Form 8-K - Current report:
SEC Accession No. 0001213900-25-105593
Filing Date
2025-11-04
Accepted
2025-11-04 07:00:58
Documents
54
Period of Report
2025-11-04
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0263497-8k_relmada.htm   iXBRL 8-K 37207
2 INVESTOR PRESENTATION, DATED NOVEMBER 4, 2025 ea026349701ex99-1_relmada.htm EX-99.1 66511
3 PRESS RELEASE, DATED NOVEMBER 4, 2025 ea026349701ex99-2_relmada.htm EX-99.2 29303
4 GRAPHIC ex99-1_001.jpg GRAPHIC 626555
5 GRAPHIC ex99-1_002.jpg GRAPHIC 617037
6 GRAPHIC ex99-1_003.jpg GRAPHIC 663411
7 GRAPHIC ex99-1_004.jpg GRAPHIC 230770
8 GRAPHIC ex99-1_005.jpg GRAPHIC 962992
9 GRAPHIC ex99-1_006.jpg GRAPHIC 650111
10 GRAPHIC ex99-1_007.jpg GRAPHIC 556957
11 GRAPHIC ex99-1_008.jpg GRAPHIC 484785
12 GRAPHIC ex99-1_009.jpg GRAPHIC 888975
13 GRAPHIC ex99-1_010.jpg GRAPHIC 633274
14 GRAPHIC ex99-1_011.jpg GRAPHIC 855162
15 GRAPHIC ex99-1_012.jpg GRAPHIC 800107
16 GRAPHIC ex99-1_013.jpg GRAPHIC 604043
17 GRAPHIC ex99-1_014.jpg GRAPHIC 625536
18 GRAPHIC ex99-1_015.jpg GRAPHIC 556861
19 GRAPHIC ex99-1_016.jpg GRAPHIC 235200
20 GRAPHIC ex99-1_017.jpg GRAPHIC 467335
21 GRAPHIC ex99-1_018.jpg GRAPHIC 297290
22 GRAPHIC ex99-1_019.jpg GRAPHIC 338338
23 GRAPHIC ex99-1_020.jpg GRAPHIC 260437
24 GRAPHIC ex99-1_021.jpg GRAPHIC 635870
25 GRAPHIC ex99-1_022.jpg GRAPHIC 375338
26 GRAPHIC ex99-1_023.jpg GRAPHIC 567612
27 GRAPHIC ex99-1_024.jpg GRAPHIC 954302
28 GRAPHIC ex99-1_025.jpg GRAPHIC 404189
29 GRAPHIC ex99-1_026.jpg GRAPHIC 505622
30 GRAPHIC ex99-1_027.jpg GRAPHIC 447896
31 GRAPHIC ex99-1_028.jpg GRAPHIC 404975
32 GRAPHIC ex99-1_029.jpg GRAPHIC 177038
33 GRAPHIC ex99-1_030.jpg GRAPHIC 826848
34 GRAPHIC ex99-1_031.jpg GRAPHIC 745788
35 GRAPHIC ex99-1_032.jpg GRAPHIC 408496
36 GRAPHIC ex99-1_033.jpg GRAPHIC 96327
37 GRAPHIC ex99-1_034.jpg GRAPHIC 386655
38 GRAPHIC ex99-1_035.jpg GRAPHIC 365708
39 GRAPHIC ex99-1_036.jpg GRAPHIC 96730
40 GRAPHIC ex99-1_037.jpg GRAPHIC 70351
41 GRAPHIC ex99-1_038.jpg GRAPHIC 241347
42 GRAPHIC ex99-1_039.jpg GRAPHIC 543647
43 GRAPHIC ex99-2_001.jpg GRAPHIC 17674
  Complete submission text file 0001213900-25-105593.txt   27366074

Data Files

Seq Description Document Type Size
44 XBRL SCHEMA FILE rlmd-20251104.xsd EX-101.SCH 3011
45 XBRL LABEL FILE rlmd-20251104_lab.xml EX-101.LAB 34239
46 XBRL PRESENTATION FILE rlmd-20251104_pre.xml EX-101.PRE 22356
56 EXTRACTED XBRL INSTANCE DOCUMENT ea0263497-8k_relmada_htm.xml XML 3694
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39082 | Film No.: 251446377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)